The information you provide to the chat will be collected and recorded to improve your experience and for quality assurance. Please read our privacy policy to see how we are storing and protecting your data.
How can we help you today?
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Recent searches
Clear History
Suggestions
All Results
Search
US | EN
QP Release in the EU clinical trial regulation: Lessons learned one year on
Webinar On Demand
It has been a year since the EU Clinical Trial Regulation has come into effect and theory has now been put into practice. We consider how pharma companies are faring and maintaining a good understanding of evolving Good Manufacturing Practice (GMP) requirements to successfully navigate the global clinical trials market, and ensure the timely supply of Investigational Medicinal Products (IMPs).
Watch this webinar to hear from a Qualified Person (Q)P as they answer pre-submitted questions about the EU Clinical Trials Regulation, how to ensure the timely supply of Investigational Medicinal Products (IMPs) and learn more about:
- Expectations and responsibilities of UK and EU QPs
- Impact of the EU Clinical Trials Regulation and its challenges
- How to ensure supply continuity across Europe
- The QP oversight process when importing into the UK
- Auditing in a post-COVID world